American Healthcare REIT, Inc. logo

American Healthcare REIT, Inc.

AHR

NYSEReal EstateREIT - Healthcare Facilities

Previous close

$55.93

+$0.16 · +0.29%

Aug 21, 4:00 PM ET

Pre-market

$55.68

−$0.25 · -0.45%

Aug 24, 7:35 AM ET

AHR company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

17

Overpriced

Momentum

49

Neutral

Sentiment

57

Mixed

Risk resilience

78

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

American Healthcare REIT (AHR) was forged through a significant strategic consolidation, combining Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, along with integrating the business and operations of American Healthcare Investors. This comprehensive merger has established AHR as a leading global real estate investment trust focused on healthcare properties, boasting an impressive portfolio with a gross investment value of approximately $4.2 billion. A core strength of the company lies in its fully integrated management platform, staffed by over one hundred highly experienced and proficient professionals. Many members of this team have a long history of collaboration, dating back to 2006, and have successfully invested in and overseen healthcare real estate assets across diverse market cycles. Their collective expertise, extensive industry network, and deep, firsthand understanding of each property within the international portfolio – which they have meticulously built and managed since its first acquisition in 2014 – are unparalleled. This powerful combination of a robust management team and a high-quality asset base strategically positions American Healthcare REIT to capitalize on compelling growth opportunities, driven by significant demographic trends. Its expansive portfolio encompasses 19 million square feet across 312 distinct properties, including medical office buildings, senior housing communities, skilled nursing facilities, and integrated senior health campuses. This diverse collection is strategically distributed across 36 U.S. states and the United Kingdom. The aforementioned tri-party transaction represented a pivotal step in ideally preparing American Healthcare REIT for a future public listing or Initial Public Offering (IPO) on a national stock exchange when market conditions are most favorable. By eventually listing its shares, the company anticipates gaining enhanced access to attractive capital sources, which will be crucial for fueling future expansion, diversifying its investor base, and providing greater liquidity for its existing stockholders. American Healthcare REIT, Inc. operates as a subsidiary of Griffin Capital Company, LLC.

Industry
REIT - Healthcare Facilities
Sector
Real Estate
Headquarters
US
CEO
Jeffrey T. Hanson
Listed since
Feb 7, 2024
Employees
121

Market position

Day range

Current $55.93

52-week range

Current $55.93

Open
$55.99
Previous close
$55.77
Volume
1.2M
0.39× average
Average volume
3.06M
Average daily volume
Market cap
11.56B USD
Beta
0.77
Market reference 1
50-day average
$53.5724
+4.40% above average
200-day average
$50.3022
+11.19% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
9.39B USD
EV / EBITDA
26.1×
Earnings yield
0.89%
Free cash flow yield
2.12%

Profitability & efficiency

Return on equity
2.10%
Return on assets
1.29%
Return on invested capital
22.20%

Financial health

Current ratio
0.37×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends23%13%3%-8%Gross margin, FY2021: 14.40%Gross margin, FY2022: 20.77%Gross margin, FY2023: 19.19%Gross margin, FY2024: 20.13%Gross margin, FY2025: 20.64%Operating margin, FY2021: 10.98%Operating margin, FY2022: 5.60%Operating margin, FY2023: 4.13%Operating margin, FY2024: 6.61%Operating margin, FY2025: 7.47%Net margin, FY2021: -3.78%Net margin, FY2022: -5.03%Net margin, FY2023: -3.84%Net margin, FY2024: -1.83%Net margin, FY2025: 3.09%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 14.40%. Gross margin FY2022 20.77%. Gross margin FY2023 19.19%. Gross margin FY2024 20.13%. Gross margin FY2025 20.64%. Operating margin FY2021 10.98%. Operating margin FY2022 5.60%. Operating margin FY2023 4.13%. Operating margin FY2024 6.61%. Operating margin FY2025 7.47%. Net margin FY2021 -3.78%. Net margin FY2022 -5.03%. Net margin FY2023 -3.84%. Net margin FY2024 -1.83%. Net margin FY2025 3.09%.

Income trends

Revenue

2.26B USD+9.15%

Operating income

168.87M USD+23.45%

Net income

69.81M USD+107.62M USD
Income trends across reported periods2.49B USD1.56B USD621.13M USD−315.44M USDRevenue, FY2021: 1.26B USDRevenue, FY2022: 1.62B USDRevenue, FY2023: 1.86B USDRevenue, FY2024: 2.07B USDRevenue, FY2025: 2.26B USDOperating income, FY2021: 138.81M USDOperating income, FY2022: 90.59M USDOperating income, FY2023: 76.72M USDOperating income, FY2024: 136.79M USDOperating income, FY2025: 168.87M USDNet income, FY2021: −47.79M USDNet income, FY2022: −81.3M USDNet income, FY2023: −71.47M USDNet income, FY2024: −37.81M USDNet income, FY2025: 69.81M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.26B USD. Revenue FY2022 1.62B USD. Revenue FY2023 1.86B USD. Revenue FY2024 2.07B USD. Revenue FY2025 2.26B USD. Operating income FY2021 138.81M USD. Operating income FY2022 90.59M USD. Operating income FY2023 76.72M USD. Operating income FY2024 136.79M USD. Operating income FY2025 168.87M USD. Net income FY2021 −47.79M USD. Net income FY2022 −81.3M USD. Net income FY2023 −71.47M USD. Net income FY2024 −37.81M USD. Net income FY2025 69.81M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue2.26B USD2.07B USD1.86B USD1.62B USD1.26B USD
Cost of goods sold1.79B USD1.65B USD1.5B USD1.28B USD1.08B USD
Gross profit466.59M USD416.78M USD356.83M USD335.97M USD182.01M USD
Selling, general, and administrative110.17M USD100.8M USD104.99M USD103.1M USD43.2M USD
Operating expenses297.73M USD279.99M USD280.11M USD245.38M USD43.2M USD
Interest expense85.78M USD127.73M USD163.19M USD105.96M USD80.94M USD
Depreciation and amortization225.2M USD221.64M USD237.3M USD200.6M USD153.81M USD
Operating income168.87M USD136.79M USD76.72M USD90.59M USD138.81M USD
Net income69.81M USD−37.81M USD−71.47M USD−81.3M USD−47.79M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
9%
1 beat, 10 misses, 0 met estimates
Average EPS surprise
-90.66%
11 comparable reports
Latest EPS result
0.16
Estimate 0.14 · Beat by 16.62%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.470.23-0.02-0.26Q1 '25MissQ2 '25MissQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26MissQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 27, 2025: actual -0.21, estimate 0.4, surprise -152.50%, Miss. Q2 2025, reported May 8, 2025: actual -0.04, estimate 0.37, surprise -110.81%, Miss. Q3 2025, reported Aug 7, 2025: actual 0.06, estimate 0.4, surprise -85.00%, Miss. Q4 2025, reported Nov 6, 2025: actual 0.33, estimate 0.42, surprise -21.43%, Miss. Q1 2026, reported Feb 26, 2026: actual 0.06, estimate 0.155, surprise -61.27%, Miss. Q2 2026, reported May 7, 2026: actual 0.13, estimate 0.161, surprise -19.20%, Miss. Q3 2026, reported Aug 6, 2026: actual 0.16, estimate 0.137, surprise +16.62%, Beat. Q4 2026, reported Nov 5, 2026: actual —, estimate 0.16, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates725.21M654.38M583.54M512.71MQ1 '25BeatQ2 '25MissQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26MissQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 27, 2025: actual 542.74M USD, estimate 542.32M USD, surprise +0.08%, Beat. Q2 2025, reported May 8, 2025: actual 540.6M USD, estimate 541.11M USD, surprise -0.09%, Miss. Q3 2025, reported Aug 7, 2025: actual 542.5M USD, estimate 552.76M USD, surprise -1.86%, Miss. Q4 2025, reported Nov 6, 2025: actual 572.94M USD, estimate 615.39M USD, surprise -6.90%, Miss. Q1 2026, reported Feb 26, 2026: actual 604.08M USD, estimate 609.48M USD, surprise -0.89%, Miss. Q2 2026, reported May 7, 2026: actual 650.77M USD, estimate 667.57M USD, surprise -2.52%, Miss. Q3 2026, reported Aug 6, 2026: actual 670.96M USD, estimate 645.3M USD, surprise +3.98%, Beat. Q4 2026, reported Nov 5, 2026: actual —, estimate 697.32M USD, surprise —, Comparison unavailable.

AHR peers

ETFs holding AHR

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research AHR

research.disclaimer